XENE vs HOMB

Comparison between Xenon Pharmaceuticals Inc (XENE, Company) and Home Bancshares Inc (HOMB, Company).

XENE is from the Healthcare sector, while HOMB is from the Financial Services sector.

5-Year PerformanceXENE has outperformed HOMB, delivering a return of +22.8% compared to +2.6%

XENE vs HOMB - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	XENE(COMPANY)	HOMB(COMPANY)
Market Cap	$5.21B	$5.24B
Max Drawdown	90.43%	65.40%
Sharpe Ratio	1.08	-0.06
5Y Beta	0.95	0.82
Industry	Biotechnology	Banks - Regional
P/E Ratio	-11.58	11.07
Forward P/E	N/A	10.74
PEG Ratio	-0.28	0.45
Dividend Yield	N/A	3.06%
5Y Dividends CAGR	N/A	13.37%
5Y EPS CAGR	40.27%	12.97%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	-5.90%	8.24%
P/S Ratio	727.44	5.00
P/B Ratio	3.90	1.24

Market Cap

XENE

$5.21B

Winner

HOMB

$5.24B

Max Drawdown

XENE

90.43%

Winner

HOMB

65.40%

Sharpe Ratio

Winner

XENE

1.08

HOMB

-0.06

5Y Beta

XENE

0.95

Winner

HOMB

0.82

Industry

XENE

Biotechnology

HOMB

Banks - Regional

P/E Ratio

Winner

XENE

-11.58

HOMB

11.07

Forward P/E

XENE

N/A

HOMB

10.74

PEG Ratio

Winner

XENE

-0.28

HOMB

0.45

Dividend Yield

XENE

N/A

HOMB

3.06%

5Y Dividends CAGR

XENE

N/A

HOMB

13.37%

5Y EPS CAGR

Winner

XENE

40.27%

HOMB

12.97%

Debt to Equity

XENE

0.00%

HOMB

0.00%

Free Cash Flow Yield

XENE

-5.90%

Winner

HOMB

8.24%

P/S Ratio

XENE

727.44

Winner

HOMB

5.00

P/B Ratio

XENE

3.90

Winner

HOMB

1.24

XENE vs HOMB - Historical Returns

Returns include dividend reinvestment.

Period	XENE	HOMB
1 month	-10.36%	+2.44%
3 months	+23.02%	-0.83%
6 months	+14.93%	-2.98%
1 year	+68.34%	+0.39%
5 years(CAGR)	+22.76%	+2.56%
10 years(CAGR)	+21.69%	+4.68%
Max(CAGR)	+14.76%	+12.84%

XENE

-10.36%

Winner

HOMB

+2.44%

Winner

XENE

+23.02%

HOMB

-0.83%

Winner

XENE

+14.93%

HOMB

-2.98%

Winner

XENE

+68.34%

HOMB

+0.39%

5Y(CAGR)

Winner

XENE

+22.76%

HOMB

+2.56%

10Y(CAGR)

Winner

XENE

+21.69%

HOMB

+4.68%

Max(CAGR)

Winner

XENE

+14.76%

HOMB

+12.84%

XENE vs HOMB - Annual Returns (2006 - 2026)

Returns include dividend reinvestment.

Year	XENE	HOMB
2026	+16.27%	-1.31%
2025	+11.58%	+2.71%
2024	-12.71%	+15.01%
2023	+23.62%	+16.48%
2022	+24.82%	-5.50%
2021	+111.94%	+27.67%
2020	+12.10%	+2.30%
2019	+96.26%	+22.07%
2018	+119.48%	-27.48%
2017	-64.01%	-14.11%
2016	-3.27%	+44.86%
2015	-57.01%	+29.34%
2014	+88.10%	-10.55%
2013	N/A	+123.80%
2012	N/A	+28.63%
2011	N/A	+14.12%
2010	N/A	+8.86%
2009	N/A	-8.65%
2008	N/A	+54.08%
2007	N/A	-13.02%
2006	N/A	+20.48%

XENE vs HOMB Drawdown Comparison

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The maximum drawdown for HOMB was -62.98%, occurring on Mar 23, 2020. Recovery took 1011 trading sessions.

The current XENE drawdown is -17.57%. The current HOMB drawdown is -11.75%.

Rank	XENE	HOMB
#1	-90.43% Jan 8, 2015 - Oct 4, 2021	-62.98% Mar 1, 2017 - Mar 8, 2021
#2	-43.59% Feb 9, 2024 - Mar 9, 2026	-52.62% Sep 18, 2008 - May 12, 2010
#3	-34.08% May 9, 2023 - Dec 22, 2023	-27.43% May 7, 2021 - Jul 16, 2024
#4	-30.14% Nov 5, 2021 - Aug 4, 2022	-26.94% Dec 23, 2013 - Jul 16, 2015
#5	-25.87% Nov 11, 2014 - Dec 11, 2014	-26.63% Nov 10, 2015 - Aug 30, 2016
#6	-17.57% Mar 9, 2026 - Jun 5, 2026	-23.12% Dec 27, 2006 - Jul 22, 2008
#7	-17.08% Mar 1, 2023 - May 3, 2023	-22.29% May 12, 2010 - Dec 22, 2011
#8	-16.98% Aug 24, 2022 - Feb 13, 2023	-21.44% Nov 26, 2024 - Apr 8, 2025
#9	-11.44% Oct 15, 2021 - Nov 2, 2021	-15.36% Sep 2, 2016 - Nov 10, 2016
#10	-11.09% Dec 11, 2014 - Dec 29, 2014	-12.09% Aug 14, 2015 - Oct 8, 2015
#11	-9.36% Feb 13, 2023 - Mar 1, 2023	-10.82% Jul 30, 2024 - Nov 6, 2024
#12	-8.58% Jan 8, 2024 - Feb 8, 2024	-10.78% Jul 3, 2006 - Nov 29, 2006
#13	-8.27% Aug 10, 2022 - Aug 24, 2022	-9.10% Dec 9, 2016 - Feb 27, 2017
#14	-6.08% Dec 29, 2014 - Jan 7, 2015	-9.02% Mar 12, 2021 - May 4, 2021
#15	-4.89% Dec 27, 2023 - Jan 8, 2024	-8.97% Aug 15, 2008 - Sep 3, 2008